143 related articles for article (PubMed ID: 38794295)
1. Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins.
Maestrelli F; Cirri M; Mennini N; Fiani S; Stoppacciaro B; Mura P
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794295
[TBL] [Abstract][Full Text] [Related]
2. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
Patel NV; Chotai NP; Patel MP
Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.
Jug M; Mennini N; Kövér KE; Mura P
J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785
[TBL] [Abstract][Full Text] [Related]
4. Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers.
Cirri M; Righi MF; Maestrelli F; Mura P; Valleri M
Drug Dev Ind Pharm; 2009 Jan; 35(1):73-82. PubMed ID: 18821153
[TBL] [Abstract][Full Text] [Related]
5. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
Jablan J; Szalontai G; Jug M
J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
Chowdary KP; Kamalakara RG
Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique.
Valleri M; Mura P; Maestrelli F; Cirri M; Ballerini R
Drug Dev Ind Pharm; 2004 May; 30(5):525-34. PubMed ID: 15244088
[TBL] [Abstract][Full Text] [Related]
10. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
Rao VM; Haslam JL; Stella VJ
J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
[TBL] [Abstract][Full Text] [Related]
11. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
Ribeiro L; Ferreira DC; Veiga FJ
J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617
[TBL] [Abstract][Full Text] [Related]
12. The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state.
Soe HMH; Chamni S; Mahalapbutr P; Kongtaworn N; Rungrotmongkol T; Jansook P
Carbohydr Res; 2020 Dec; 498():108190. PubMed ID: 33160203
[TBL] [Abstract][Full Text] [Related]
13. Enhancing solubility and stability of sorafenib through cyclodextrin-based inclusion complexation:
Aman A; Ali S; Mahalapbutr P; Krusong K; Wolschann P; Rungrotmongkol T
RSC Adv; 2023 Sep; 13(39):27244-27254. PubMed ID: 37701271
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions in remdesivir-cyclodextrin systems.
Várnai B; Malanga M; Sohajda T; Béni S
J Pharm Biomed Anal; 2022 Feb; 209():114482. PubMed ID: 34856493
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
16. Development of Oral Tablet Formulation Containing Erlotinib: Randomly Methylated-β-cyclodextrin Inclusion Complex Using Direct Compression Method.
Erdoğar N
Turk J Pharm Sci; 2021 Oct; 18(5):589-596. PubMed ID: 34719186
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.
Mangas-Sanjuan V; Gutiérrez-Nieto J; Echezarreta-López M; González-Álvarez I; González-Álvarez M; Casabó VG; Bermejo M; Landin M
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):795-806. PubMed ID: 26602766
[TBL] [Abstract][Full Text] [Related]
19. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems.
Nalluri BN; Chowdary KP; Murthy KV; Becket G; Crooks PA
AAPS PharmSciTech; 2007 May; 8(2):Article 36. PubMed ID: 17622114
[TBL] [Abstract][Full Text] [Related]
20. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
Wang L; Zeng F; Zong L
Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
